December 1: The Week in Cancer News
FDA announces investigation into CAR T-cell therapy, and precision therapies are not available for most cancer diagnoses.
Progress Against Cancer
FDA announces investigation into CAR T-cell therapy, and precision therapies are not available for most cancer diagnoses.
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
Sun exposure is an occupational hazard around the globe, and a dormant virus can cause immunotherapy complications.
New recommendation suggests ongoing lung cancer screening for those with heavy smoking history even after quitting, and more.
For our readers who enjoy learning about the newest tools and strategies in cancer research, the second installment of...
Immunotherapy drug approved as pre- and post-surgery treatment for non-small cell lung cancer, and bladder cancer patients who respond...
Researchers share approaches for improving participation among underrepresented groups at AACR conference.
Rising prevalence of non-melanoma skin cancer leads to more deaths across the globe and other highlights from this week...
Minority groups less likely to receive palliative care, and radiation oncology meeting focuses on shorter radiation courses.
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...